血清丙氨酸转氨酶正常的慢性丙型肝炎的治疗
Treatment in chronic hepatitis C patients with normal serum alanine aminotransferase
摘要
丙型肝炎病毒(HCV)感染的流行较为广泛,呈全球性分布。慢性丙型肝炎患者如得不到及时和合理的治疗,可发展为肝硬化、肝细胞癌。对血清丙氨酸转氨酶(alanine aminotransferase,ALT)升高的慢性丙型肝炎患者的治疗早已取得共识,即应采取积极的抗病毒治疗;但对ALT正常的慢性丙型肝炎患者是否应该常规接受抗HCV治疗,长期以来一直存在分歧。本文对ALT正常的慢性丙型肝炎的流行病学、自然史和治疗等研究进展作简要的介绍。
出处
《中国感染与化疗杂志》
CAS
2006年第5期356-360,共5页
Chinese Journal of Infection and Chemotherapy
参考文献25
-
1Dufour DR,Lott JA,Nolte FS,et al.Diagnosis and monitoring of hepatic injury.I.Performance characteristics of laboratory tests[J].Clin Chem,2000,46:2027-2049.
-
2Robert J,Pokorski.Hepatitis C Virus Infection in Japan[J].Risk Insights,2001,2:33-38.
-
3Bacon BR.Treatment of patients with hepatitis C and normal serum aminotransferase levels[J].Hepatology,2002,36(5 Suppl):S179-S184.
-
4Ahmed A,Keeffe EB.Chronic hepatitis C with normal aminotransferase levels[J].Gastroenterology,2004,126:1409-1415.
-
5Puoti C,Castellacci R,Montagnese F,et al.Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels:the Italian prospective study of the asymptomatic C carriers (ISACC)[J].J Hepatol,2002,37:117-123.
-
6刘玉振,邢培清,李伍升,方建华,温涛.无偿献血人群中ALT、抗-HCV和HBsAg阳性模式分布调查[J].解放军预防医学杂志,2004,22(4):278-279. 被引量:5
-
7Shiffman ML,Stewart CA,Hofmann CM,et al.Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels:comparison of hepatic histology and response to interferon therapy[J].J Infect Dis,2000,182:1595-1601.
-
8Pradat P,Alberti A,Poynard T,et al.Predictive value of ALT levels for histologic findings in chronic hepatitis C:a European collaborative study[J].Hepatology,2002,36:973-977.
-
9Jamal MM,Soni A,Quinn PG,et al.Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States[J].Hepatology,1999,30:1307-1311.
-
10Persico M,Persico E,Suozzo R,et al.Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels[J].Gastroenterology,2000,118:760-764.
二级参考文献16
-
1Camma C, Bruno S, Schepis F, et al. Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta- analysis of individual patient data[ J ]. Gut, 2002,51:864-869.
-
2Papatheodoridis GV, Papadimitropoulos VC, Hsdziyannis SJ. Effect of interferon therapy on the development of hepatocellular carcinoma in patients with hepatitis C virus- reated cirrhosis: a meta- analysis[J] .Aliment Pnarmaool Ther, 2001,15:689- 698.
-
3Kjaergard LL, Krogsgaard K, Gluud C. Interfern alfa with or without ribavirin for chronic hepatitis C: systematic review of randonmised trials[J].BMJ, 2001,323:1151 - 1155.
-
4Alberti A, Benvegnu L. Management of hepatitis[J] .J Hepatol, 2003,38(Suppl1): S1014 - S1 18.
-
5Poynard T, MdHutchison J, Davis GL, et al. Impact of interferon alfa - 2b and ribavirin on progression of liver fibrosiis in patients with chronic hepatitis C[J].Hepatology, 2000,32:1131 - 1137.
-
6Booth JCL, O' Grady J, Neuberger J. Clinical guidelines on the mangement of hepatitis C[J]. Gut, 2001, 49(Suppl I ): il - i12.
-
7Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systemic review[J]. Hepatology, 2002, 36(5 Suppl 1 ):S135 - S144.
-
8Di Ciomm no V, Russo P, Rava L, etal. Interferon alpha in the treatment of chronic hepatitis C in children: a mmeta- analysis[J] .J Viral Hepat,2003,10:210 - 214.
-
9Fabrizi F, Dulai G, DixitV, et al. Meta- analysis: interfeorn for the treatment of chronic hepatitis C in dialysis patients[J] .Aliment Phamacol Ther, 2003,18:1071 - 1081.
-
10National Institute of Health Consensus Development Conference Panel Statenent. Management of hepatitis C[J].Hepatology, 2002,36(5 Suppl 1):S3- S20.
共引文献738
-
1刘洋,李宁,杨文杰,孙国清,李洁,刘春华,张国龙,赵东阳.2019年河南省慢性病监测点医院就诊者丙型肝炎感染状况调查[J].河南预防医学杂志,2021,32(4):256-258. 被引量:1
-
2董婕,孙洪清.艾滋病患者外周血淋巴细胞计数取代CD4^+T细胞计数监测HAART疗效[J].现代免疫学,2008,28(4):331-334. 被引量:2
-
3吴建瑜.丙型肝炎患者健康教育需求调查[J].实用医技杂志,2008,15(27):3803-3805. 被引量:1
-
4李鹏.丙型肝炎病毒核心抗原检测技术的现状[J].临床输血与检验,2011,13(2):191-192. 被引量:3
-
5高庆伟,袁德胜,王金荣,张勇,孙伟翔,王淑兰.脱氧核苷酸钠注射液治疗慢性丙型肝炎临床疗效分析[J].中国肝脏病杂志(电子版),2010,2(1):29-31. 被引量:3
-
6肝纤维化中西医结合诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):54-59. 被引量:107
-
7王雪,徐凌中.济南市无偿献血人群血液检测结果分析[J].医学检验与临床,2008,0(1):17-18. 被引量:13
-
8吴杭源,朱银芳,华忠,徐淑凡,过小叶,姚上志.苦参素联合胸腺肽α1治疗失代偿期肝硬化的抗病毒疗效观察[J].中国生化药物杂志,2014,34(5):143-145. 被引量:15
-
9陈红梅.丙型肝炎的临床表现及诊治[J].西藏科技,2004(7):24-26. 被引量:1
-
10陈红梅.丙型肝炎的预防[J].西藏科技,2004(7):31-32.
-
1何丽.干扰素α致甲状腺功能异常21例临床分析[J].临床误诊误治,2014,27(4):66-68.
-
2马丽丽.经血途径传播慢性丙型肝炎病人临床流行病学分析[J].世界感染杂志,2006,6(4):329-330.
-
3吴逸如,刘莎,刘文虎.慢性肾脏病合并慢性丙型肝炎的诊治研究进展[J].中国全科医学,2016,19(15):1833-1836. 被引量:7
-
4李新华,王会琳,曹春蕊.血清自身抗体对干扰素治疗慢性丙型肝炎疗效的影响[J].疑难病杂志,2011,10(2):138-139. 被引量:7
-
5叶云,郭琴芳,谭友文.慢性丙型肝炎患者治疗依从性及影响因素的研究[J].中华护理教育,2015,12(12):885-888. 被引量:4
-
6申川,赵彩彦,张文宏.慢性丙型肝炎合并自身免疫性疾病的诊治[J].中国实用内科杂志,2016,36(3):180-184. 被引量:1
-
7时佳,沈震,苗慧,杨宗国,徐庆年,陆云飞,吕莹,陈晓蓉.血脂水平与慢性丙型肝炎患者抗病毒疗效的相关性分析[J].临床肝胆病杂志,2014,30(6):496-500. 被引量:4
-
8南月敏,张玉果.丙型肝炎肝纤维化诊治进展[J].传染病信息,2013,26(3):141-145. 被引量:6
-
9刘广艳,李新华,王会琳,张建军,王宏,曹春蕊.慢性丙型肝炎合并混合性冷球蛋白血症患者血清自身抗体的检测[J].中西医结合肝病杂志,2015,25(5):298-300. 被引量:1
-
10程莹,谭志辉,朴美善.聚乙二醇干扰素治疗慢性丙型肝炎疗效观察[J].中国临床研究,2010,23(4):318-318. 被引量:2